ES464571A1 - Procedimiento para la obtencion de derivados del inhibidor de tripsina-calicreina. - Google Patents

Procedimiento para la obtencion de derivados del inhibidor de tripsina-calicreina.

Info

Publication number
ES464571A1
ES464571A1 ES464571A ES464571A ES464571A1 ES 464571 A1 ES464571 A1 ES 464571A1 ES 464571 A ES464571 A ES 464571A ES 464571 A ES464571 A ES 464571A ES 464571 A1 ES464571 A1 ES 464571A1
Authority
ES
Spain
Prior art keywords
bpti
derivatives
trypsin
medicaments
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES464571A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of ES464571A1 publication Critical patent/ES464571A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • C07K14/8117—Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)

Abstract

Procedimiento para la obtención de derivados inhibidor de tripsina-calicreina de órganos de resescuyos restos tirosina 10 y/o 21 están enlazados en la posición orto con respecto al grupo hidroxilo fenólico a través de un grupo azoico con un resto aromático o heterocíclicoen caso dado sustituido y donde adicionalmente el otro de los dos restos tirosina 10 a 21 lleva un grupo nitro en la posición orto con respecto al grupo hidroxilo fenólicocaracterizado porque BPTI o derivados del BPTI según métodos en si conocidos se copulan con compuestos diazónicos aromáticos o heterocíclicosque en caso dado pueden estar sustituidosy los derivados de azo-BPTI formados se aislan.
ES464571A 1976-11-29 1977-11-29 Procedimiento para la obtencion de derivados del inhibidor de tripsina-calicreina. Expired ES464571A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19762654124 DE2654124A1 (de) 1976-11-29 1976-11-29 Derivate des trypsin-kallikrein-inhibitors aus rinderorganen (bpti) mit proteasenhemmwirkung und antiphlogistischer wirkung, ihre herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
ES464571A1 true ES464571A1 (es) 1978-09-01

Family

ID=5994225

Family Applications (1)

Application Number Title Priority Date Filing Date
ES464571A Expired ES464571A1 (es) 1976-11-29 1977-11-29 Procedimiento para la obtencion de derivados del inhibidor de tripsina-calicreina.

Country Status (10)

Country Link
US (1) US4153687A (es)
JP (1) JPS5368701A (es)
BE (1) BE861267A (es)
DE (1) DE2654124A1 (es)
DK (1) DK526077A (es)
ES (1) ES464571A1 (es)
FR (1) FR2373516A1 (es)
GB (1) GB1557599A (es)
NL (1) NL7713091A (es)
SE (1) SE7713436L (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748294A1 (de) * 1977-10-27 1979-05-03 Bayer Ag Neue derivate des bpti, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2748295A1 (de) * 1977-10-27 1979-05-03 Bayer Ag Neue derivate des bpti
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
ATE277081T1 (de) 1994-01-11 2004-10-15 Dyax Corp Inhibitoren des humanplasmins, die sich von den kunitz domänen ableiten
WO1995021601A2 (en) * 1994-01-11 1995-08-17 Protein Engineering Corporation Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
US6057287A (en) 1994-01-11 2000-05-02 Dyax Corp. Kallikrein-binding "Kunitz domain" proteins and analogues thereof
US20040054082A1 (en) * 2001-12-03 2004-03-18 Bank David H Toughened polymer blends with improved surface properties
ES2348230T3 (es) * 2002-06-07 2010-12-01 Dyax Corp. Prevención y reducción de la isquemia.
US7153829B2 (en) * 2002-06-07 2006-12-26 Dyax Corp. Kallikrein-inhibitor therapies
EP2386310B1 (en) * 2002-08-28 2018-11-07 Dyax Corp. Methods for preserving organs and tissues
US7235530B2 (en) 2004-09-27 2007-06-26 Dyax Corporation Kallikrein inhibitors and anti-thrombolytic agents and uses thereof
US7276480B1 (en) 2005-12-30 2007-10-02 Dyax Corp. Prevention and reduction of blood loss
EP2001500A4 (en) * 2006-03-10 2010-07-28 Dyax Corp FORMULATIONS FOR ECALLANTIDE
US8637454B2 (en) * 2009-01-06 2014-01-28 Dyax Corp. Treatment of mucositis with kallikrein inhibitors
SMT201800552T1 (it) 2010-01-06 2018-11-09 Dyax Corp Proteine che legano la callicreina plasmatica
KR102320178B1 (ko) 2011-01-06 2021-11-02 다케다 파머수티컬 컴패니 리미티드 혈장 칼리크레인 결합 단백질
EP3320922A1 (en) 2011-06-10 2018-05-16 Ionis Pharmaceuticals, Inc. Methods for modulating kallikrein (klkb1) expression
US9322021B2 (en) 2011-06-29 2016-04-26 Ionis Pharmaceuticals, Inc. Methods for modulating kallikrein (KLKB1) expression
KR102365486B1 (ko) 2013-08-28 2022-02-18 아이오니스 파마수티컬즈, 인코포레이티드 프리칼리크레인 (pkk) 발현의 조절
US10428158B2 (en) 2014-03-27 2019-10-01 Dyax Corp. Compositions and methods for treatment of diabetic macular edema
HUE052709T2 (hu) 2014-05-01 2021-05-28 Ionis Pharmaceuticals Inc Módosított antiszensz oligonukleotidok konjugátumai és azok alkalmazása PKK expressziójának módosítására
EP3387018A1 (en) 2015-12-11 2018-10-17 Dyax Corp. Plasma kallikrein inhibitors and uses thereof for treating hereditary angioedema attack
EP4090427A1 (en) 2020-01-13 2022-11-23 Takeda Pharmaceutical Company Limited Plasma kallikrein inhibitors and uses thereof for treating pediatric hereditary angioedema attack

Also Published As

Publication number Publication date
BE861267A (fr) 1978-05-29
US4153687A (en) 1979-05-08
FR2373516B1 (es) 1980-06-13
DK526077A (da) 1978-05-30
DE2654124A1 (de) 1978-06-01
SE7713436L (sv) 1978-05-30
NL7713091A (nl) 1978-05-31
JPS5368701A (en) 1978-06-19
FR2373516A1 (fr) 1978-07-07
GB1557599A (en) 1979-12-12

Similar Documents

Publication Publication Date Title
ES464571A1 (es) Procedimiento para la obtencion de derivados del inhibidor de tripsina-calicreina.
ES2042861T3 (es) Procedimiento para la fabricacion de poliisocianatos modificados.
SE7704928L (sv) Desaminoderivat av kallikrein-trypsin-inhibitor, sett for framstellningen derav samt anvendning derav som lekemedel
IT1082182B (it) Fascia per caviglia e relativo procedimento di impiego
ES2037013T3 (es) Procedimiento para preparar tieno-1,4-diazepinas.
MX18736A (es) Inhibidores retrovirales de proteasa y procedimiento para su preparacion.
DK283180A (da) Polypeptider og derivater deraf
AR228458A1 (es) Compuestos derivados de sulfonatos de 2-hidroxi-n-(pirimidin-2-il o 1,3,5-triazin-2-il)aminocarbonil bencenosulfonamida,composicion que los contiene,procedimiento y producto intermedio para prepararlos
MX9204237A (es) Nuevos derivados de ciclohexano y tetrahidropiran, procedimiento para su preparacion y composicion antifungal que los contiene.
MX9102499A (es) Derivados de benzamida, procedimiento para su preparacion y composicion farmaceutica que los contiene.
BG32412A3 (en) Akaracide means
IT7926560A0 (it) Procedimento perfezionato per lapreparazione di idroperossidi aromatici.
NL7600116A (nl) Aromatiseringsmiddel.
ES8104995A1 (es) Procedimiento para la preparacion de un derivado de 2-hidro-xi-5-(1-hidroxi-2-piperaciniletil)benzoico
ES2181667T3 (es) Composiciones nuevas de ciclina a humana y su procedimiento de produccion, secuencia nucleotidica correspondiente, procedimiento y agentes para la deteccion o diagnostico de la proliferacion celular y procedimiento y agentes para la inhibicion de la proliferacion celular.
AR240042A1 (es) Derivados de acidos 7-ariloxi-naftil-2-oxi)-alcanacorboxilicos, procedimientos para su preparacion y composicones herbicidas que los contienen.
NO142716C (no) Fremgangsmaate for aa gjenopprette de mekaniske egenskaper i brukte deler av haarde, sproee, stoepte superlegeringer
ES8104802A1 (es) Procedimiento de preparacion de agentes antifungicos sinergicos.
SE411670B (sv) 2-klor-n-isopropyl-2',3'-dimetylacetanilid till anvendning som herbicidalt medel och forfarande for dess framstellning
AR225937A1 (es) Procedimiento para preparar derivados de(amino-3-hidroxi-2-propoxi)-imino-4-tetrahidro-4,5,6,7-benzo(b),o tetrihidro-5,6,7,8-4h ciclopenta(b)-o dihidro 5,6,-4h-ciclopenta(b)-tiofeno
ES2134276T3 (es) Procedimiento para la preparacion de derivados isopropilidenicos de sacaridos.
JPS53147044A (en) Guanidinobenzoic acid derivative and its preparation
ES418338A1 (es) Procedimiento para la obtencion de 2-aril-v-triazoles.
DE3160437D1 (en) Water soluble polyesters and polycarbonates for use as antitumor agents
SU665347A2 (ru) Реле защиты